Document is current

Article History

Accepted: 11 March 2025

First Online: 2 April 2025

Declarations

:

: Neil O’Connor, Jamie Kim, Sumita Pradhan, Litha Jaison, Rusha Chakraborty, Fathima Majeed, and Lisa Soyeon Park received a salary as employees of Prestige Biopharma Limited. Hervé Bischoff, Bogdan Valentin Popescu, Cécile Bigot, Lotfi Boudali, Alexandre Detappe, and Pierre Coliat certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this article. Xavier Pivot reported being an unpaid adviser for Prestige Biopharma Limited but owned shares of the company.

: Ethics approval is not applicable for this study, as it is a preclinical study that does not involve human participants.

: Not applicable.

: Not applicable.

: The application providing the project details should be submitted to Prestige BioPharma Ltd, (21 Biopolis Road, #04-24 Nucleos South Building, Singapore 138567) and will be approved by the steering committee of the study before releasing the data.

: Not applicable.

: LSP, XP, NOC, HB, PC, RC, and JK made substantial contributions to the design of the work; NOC, RC, and LJ made substantial contributions to data acquisition and performed the biosimilarity analysis; all contributors performed the interpretation of data for the work; NOC, XP, HB, PC, and BVP drafted the work; all authors revised the manuscript critically for important intellectual content, and all have read and approved the final version.

: This study was supported by Prestige Biopharma Limited.